Ten years of data suggest that AREDS2 supplements are associated with a reduced risk of macular degeneration progression without any increase in lung cancer risk, according to a follow-up study published online June 2, 2022, by JAMA Ophthalmology.
Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
Your new post is loading...
Your new post is loading...
|
|